What is Esperion Therapeutics's common stock?

Esperion Therapeutics (ESPR) reported common stock of 480M in Q1 2026.

How has Esperion Therapeutics's common stock changed year-over-year?

Esperion Therapeutics's common stock decreased by 0.0% year-over-year, from 480M to 480M.

What is the long-term trend for Esperion Therapeutics's common stock?

Over 5 years (2020 to 2025), Esperion Therapeutics's common stock has grown at a 32.0% compound annual growth rate (CAGR), from 120M to 480M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Esperion Therapeutics ESPR Common Stock

Common Stock at other companies

AmgenAMGN

2.8B0.0%

NewAmsterdam Pharma CompanyNAMS

$14.59M+4.5%

Lexicon PharmaceuticalsLXRX

450M0.0%

Zevra Therapeutics, Inc.ZVRA

$6K+20.0%

Eton Pharmaceuticals, Inc.ETON

$27K0.0%

Nurix Therapeutics, Inc.NRIX

500M0.0%

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's common stock?: Esperion Therapeutics (ESPR) reported common stock of 480M in Q1 2026.
How has Esperion Therapeutics's common stock changed year-over-year?: Esperion Therapeutics's common stock decreased by 0.0% year-over-year, from 480M to 480M.
What is the long-term trend for Esperion Therapeutics's common stock?: Over 5 years (2020 to 2025), Esperion Therapeutics's common stock has grown at a 32.0% compound annual growth rate (CAGR), from 120M to 480M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).